-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-executive-170523.pdf
May 01, 2017 - ), and balance and coordination
(vestibular function). … quality of
life and intermediate outcomes related to the incidence and
duration of otorrhea. … and parental quality of life, duration of otorrhea, and
need for removal of TT. … ,
language, and behavioral) in 1665 children over multiple
time points and arms. … and NRCSs
included in KQs 1 and 2.
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs022335-juckett-final-report-2017.pdf
January 01, 2017 - of administrative data, dictated and formatted
progress notes, and regular patient reported outcomes … and Results
1. … , and
results are linked to word positions in document
1.5 Store all classes and scores linked to … in Methods and in Figure 1. … The recall, precision, and F1 scores between human annotators and the algorithm
was 0.90, 0.93, and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - to mortality, morbidity, and health care costs.1-3 Diabetes-related
complications were the seventh … cerebrovascular
morbidity and mortality, retinopathy, nephropathy, and neuropathy? … cerebrovascular morbidity and mortality, retinopathy, nephropathy, and
neuropathy? … The Downs and Black tool and other inclusion criteria for
nonrandomized trials and observational studies … and 2-drug combinations.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-12/health-equity-framework-report.pdf
January 01, 2023 - of
the Antiracism and Health Equity Work Group and in particular Esa Davis, MD, MPH, and Iris Mabry … Racism and health I: pathways and scientific evidence. … Food and Drug Administration (FDA)
Partners Focused on Healthcare Utilization, Coverage, and Quality … obesity” and “people who have
overweight and obesity,” rather than “overweight and obese people” or … o Rationale: Clarity and specificity helps to increase understanding and relevance
of messages and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-220-disposition-comments-analgesics-prehospital-setting.pdf
September 03, 2019 - and outcomes for SOE grading. … of comparisons and outcomes for
which conclusions were constructed and
graded. … and mental
status changes. … and mental
status changes. … and
Peripheral
Nerves
General The AANS/CNS Joint Sections on Pain and
Disorders of the Spine and
-
digital.ahrq.gov/sites/default/files/docs/citation/u19hs021093-lambert-final-report-2017.pdf
January 01, 2017 - Antidepressant treatment
and suicide attempts and self-inflicted injury in children and adolescents. … Gibbons and Anup Amatya. Chapman and Hall, 2015. … Antidepressant treatment
and suicide attempts and self-inflicted injury in children and adolescents … (age, race, and gender), pain medication orders (opioids,
nonopioids, and no medications), and medical … and
diltiazem, hydroxyzine and hydralazine, Paxil and Taxol, fomepizole and omeprazole, Foradil and
-
www.ahrq.gov/sites/default/files/2024-01/lambert-report.pdf
January 01, 2024 - Antidepressant
treatment and suicide attempts and self-inflicted injury in children and adolescents. … Gibbons and Anup Amatya. Chapman and Hall, 2015. … Antidepressant treatment
and suicide attempts and self-inflicted injury in children and adolescents … (age, race, and gender), pain medication
orders (opioids, nonopioids, and no medications), and medical … and diltiazem, hydroxyzine and hydralazine, Paxil and Taxol, fomepizole and omeprazole, Foradil and
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Hougland_26.pdf
October 01, 2011 - increased health care costs.1, 2, 3, 4 There is increasing interest in improved methods of AE
surveillance … 10 and 20
years old. … , Utah and Missouri. … Masheter, and
Dr. … Incidence
and types of adverse events and negligent care in Utah
and Colorado.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-205-fullreport.pdf
January 01, 2014 - and referral and include: the Administration for Children and Families;
the Centers for Disease Control … and follow-up. … services and also to improve
the identification and referral rates and promptly link at-risk children … Ashe Pediatrics is a Level III Medical Home
and vaccines and hearing, vision, and developmental screenings … Vision Specialists, and Mental
Health Specialist; and three, one or more CPT and/or ICD-9-CM codes
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZSVRTLv938Gtr5au4-6eYL
September 01, 2024 - the benefits and harms of breast cancer screen-
ing strategies that varied by the ages to start and … , “real-world”
treatment assignment and effects for women overall and for Black
women. … annual start-
ing at age 40) (Figure 1; eFigures 1 and 2 and eTable 6 in the Supple-
ment). … Clinical Practice and Departments
of Medicine and Community and Family Medicine,
Dartmouth Geisel School … and take responsibility for the integrity of the
data and the accuracy of the data analysis.
-
digital.ahrq.gov/sites/default/files/docs/page/privacy-and-security-solutions-for-interoperable-hie-avas-executive-summary.pdf
June 30, 2007 - specifying the purpose and use of the data, consent and authorization policies and
procedures, data … , patient notification (including accounting and audit of prospective
and retrospective data uses and … for providers
to invest in technology that will advance the utilization of private and secure HIE … of privacy and security solutions; and
ancillary issues and solutions. … and regulatory solutions;
technological and data standards solutions; and
education and outreach
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pediatric-ehr_disposition-comments.pdf
May 01, 2015 - between pediatric and adult care and the
differences in the roles and expectations of the impact
of … For instance, school located
vaccines, growth and development records in schools
and readiness and … GQ4 explores
testability and usability issues and challenges that
impact dissemination and development … is
completed and that data are reported and final
diagnoses recorded and shared. … , and between public health and both
inpatient and primary care to complete the screening
process and
-
digital.ahrq.gov/sites/default/files/docs/publication/r36hs018239-taha-final-report-2011.pdf
January 01, 2011 - the performance of tasks using a portal; and 3) identify usability
problems and initial design solutions … Methods: Participants were evaluated with a cognitive battery and health literacy and numeracy
tests … , and
graphs. … ), and Adequate (75-100). … audio and/or video explanations
could be added to help patients understand and interpret this and other
-
www.ahrq.gov/sites/default/files/2024-12/bailit-aron-love-report.pdf
January 01, 2024 - Quality and the National Institute of Child Health and Development. … factors; and to develop and
validate models of the relationships between hospital structural and process … of hospitalization in the US.1, 2 AHRQ has included several
childbirth measures of quality in its Healthcare … Cost and Utilization Project (HCUP).3
An ideal quality measure for inpatient obstetrics would encompass … are also very similar with and without race and ethnicity.
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/20140115_DB/Final_Using_the_CAHPS_Database_Webcast_Transcript.pdf
January 01, 2014 - And that includes links to the CAHPS Database Web site and the Online Reporting
System and several other … And finally, we do offer customized analyses and
reports upon request as time and resources allow. … And this gives the break out of the N and percent for each. … And so there’s a logic and link between HCAHPS and CG-CAHPS. … And then those records are marked complete. And then we process and
report that data.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening-july-2016
August 09, 2016 - The long-term benefits and harms of statin use in children and adolescents are unknown. … However, the clinical health benefits and risks among children and adolescents identified with and treated … in children and adolescents 20 years or younger is insufficient and that the balance of benefits and … AHRQ and the U.S. … Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/implementation-guides/implementation-guide1/impguide1.pdf
September 08, 2015 - and efficiently. … – Communication content and mechanisms, both internal and external. … Meetings
are structured and include training, education, team-building activities,
and full-group and … and recovery. … ,
including development of a Web site and vision and mission statements
to inform and engage additional
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/xUc_vXf7323faUQY7SePhT
January 01, 2002 - Researchers
and participants were blinded in 3 trials (PHS,
HOT, and TPT). … In BMD and PPP, participants
were not blinded and were not given placebo pills. … treatment and control groups. … Utilization of our results from our review in
shared decision-making with patients requires an
estimation … Estimates of benefits and harms should be
interpreted and compared cautiously.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/2kM7LY6ccceVo8bmdUXhYm
September 01, 2002 - and for analyzing data. … (0.80 and 0.79, respectively [sensitivity, 99.6 percent
and 97.5 percent, and specificity, 17.9 percent … and calcitonin for
osteoporosis prevention and/or treatment. … activity, low exposure to
sunlight, and low consumption
of calcium and tea. … Treatment costs also
vary; alendronate currently costs approximately $3
per daily dose.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/osteoporosis-screening-2002
September 17, 2002 - lists; and experts. … and for analyzing data. … (0.80 and 0.79, respectively [sensitivity, 99.6 percent and 97.5 percent, and specificity, 17.9 percent … Treatment costs also vary; alendronate currently costs approximately $3 per daily dose. … Agency for Health Care Policy and Research, U.S. Department of Health and Human Services.